Metraipolis › archive › dc_c43bfde13d5e
Efficacy and safety of semaglutide for obesity and hyperphagia in adults with Prader-Willi syndrome — Europe PMC PMID:42755517
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42755517
- DOI
- 10.3389/fendo.2026.1881392
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-16T05:52:25.112Z
- SHA-256 of the archived text
628a91f8aca35bfac2542f4111d5b02cc3cca3b3a1a081f593596b47e44d3a47- Stable URL of this page
https://metraipolis.com/documento/dc_c43bfde13d5e
How to cite
Efficacy and safety of semaglutide for obesity and hyperphagia in adults with Prader-Willi syndrome — Europe PMC PMID:42755517 — Europe PMC (en), https://europepmc.org/article/MED/42755517 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_c43bfde13d5e (Metraipolis archive dc_c43bfde13d5e, sha256 628a91f8aca35bfac2542f4111d5b02cc3cca3b3a1a081f593596b47e44d3a47)
BibTeX
@misc{dcc43bfde13d5e,
title = {Efficacy and safety of semaglutide for obesity and hyperphagia in adults with Prader-Willi syndrome — Europe PMC PMID:42755517},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42755517},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_c43bfde13d5e; sha256 628a91f8aca35bfac2542f4111d5b02cc3cca3b3a1a081f593596b47e44d3a47},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42755517. Agents can read the archived copy with the MCP tool read_document.